T1	SNP 0 21	Genetic polymorphisms
T2	Entity 39 43	Nek2
T3	Entity 25 34	centrobin
R2	SNP_coupled_gene Arg1:T1 Arg2:T2	
T4	Association 48 58	associated
E1	Association:T4 bc:T5 snp_int:T1 snp_int2:T6
T5	Cancer 64 77	breast cancer
T6	SNP 0 21	Genetic polymorphisms
R1	SNP_coupled_gene Arg1:T6 Arg2:T3	
T7	Entity 98 120	Chinese Han population
R3	Population_assignment Arg1:T1 Arg2:T7	
R4	Population_assignment Arg1:T6 Arg2:T7	
T9	SNP 431 452	genetic polymorphisms
T10	Spec 472 475	may
T11	Association 476 482	affect
E2	Association:T11 bc:T12
T12	Cancer 483 496	breast cancer
R5	Speculation_marker Arg1:E2 Arg2:T10	
T13	Entity 515 537	Chinese Han population
R6	Population_assignment Arg1:T9 Arg2:T13	
R7	Member Arg1:T9 Arg2:T6	
R8	Member Arg1:T9 Arg2:T1	
T8	SNP 577 608	single nucleotide polymorphisms
T14	SNP 572 608	Five single nucleotide polymorphisms
T15	SNP 610 614	SNPs
R9	Equiv Arg1:T15 Arg2:T8	
T16	Entity 619 628	centrobin
R10	SNP_coupled_gene Arg1:T14 Arg2:T16	
T17	SNP 633 642	four SNPs
T18	Entity 646 650	Nek2
R11	SNP_coupled_gene Arg1:T17 Arg2:T18	
T19	Entity 766 788	Chinese Han population
R12	Population_assignment Arg1:T17 Arg2:T19	
R13	Population_assignment Arg1:T8 Arg2:T19	
T20	Interaction 814 829	CATCG haplotype
E3	Interaction:T20 Entity:T26
T21	Entity 833 842	centrobin
R14	SNP_coupled_gene Arg1:E3 Arg2:T21	
T22	Level 847 855	strongly
T23	Association 896 900	risk
E4	Association:T23 snp_int:E3 bc:T39
T24	Effect_Type 872 881	decreased
R15	Effect_type_marker Arg1:E4 Arg2:T24	
R16	Level_marker Arg1:E4 Arg2:T22	
A1	Level E4 High
A2	Effect_Type E4 Decrease
T25	Entity 975 983	C allele
T26	SNP 991 1001	rs11650083
T27	Entity 1003 1006	A>C
T28	Entity 1019 1026	exon 12
T29	SNP 1041 1050	Pro578Gln
R17	Nucleotide_substitution Arg1:T26 Arg2:T27	
R18	SNP_allele Arg1:T26 Arg2:T25	
R19	SNP_location Arg1:T26 Arg2:T28	
R20	Equiv Arg1:T26 Arg2:T29	
T30	Organic_inorganic_molecules_affected 1041 1050	Pro578Gln
E5	Organic_inorganic_molecules_affected:T30 Theme:T31 Agent:T26
T31	Entity 1041 1047	Pro578
A3	SNP_Type T26 Missense
T32	Entity 1084 1088	Nek2
A4	SNP_Type T29 Missense
T33	SNP 1065 1080	individual SNPs
R21	Equiv Arg1:T17 Arg2:T33	
T34	Neg 1053 1057	None
T35	Association 1093 1103	associated
E6	Association:T35 bc:T36 snp_int:T33
T36	Cancer 1109 1122	breast cancer
R22	Negation_marker Arg1:E6 Arg2:T34	
R23	SNP_coupled_gene Arg1:T33 Arg2:T32	
T37	Interaction 1138 1152	haplotype GTAT
E7	Interaction:T37 
T38	Entity 1156 1160	Nek2
R24	SNP_coupled_gene Arg1:E7 Arg2:T38	
T39	Cancer 882 895	breast cancer
T40	Association 1191 1195	risk
E8	Association:T40 snp_int:E7 bc:T42
T41	Effect_Type 1181 1190	increased
A5	Effect_Type E8 Increase
R25	Effect_type_marker Arg1:E8 Arg2:T41	
T42	Cancer 1199 1212	breast cancer
T43	Association 1263 1267	risk
E9	Association:T43 snp_int:E10 bc:T42
T44	Level 1272 1285	significantly
T45	Effect_Type 1286 1294	elevated
R26	Level_marker Arg1:E9 Arg2:T44	
R27	Effect_type_marker Arg1:E9 Arg2:T45	
A6	Effect_Type E9 Increase
A7	Level E9 High
T46	Entity 1301 1306	women
T47	Entity 1317 1341	family history of cancer
T48	Entity 1355 1389;1397 1405;1407 1416	menarche-first full-term pregnancy interval >11Â years
T49	Entity 1364 1389	first full-term pregnancy
T50	Entity 1391 1395	FFTP
R28	Equiv Arg1:T50 Arg2:T49	
T51	Interaction 1138 1152	haplotype GTAT
E10	Interaction:T51 
R29	SNP_coupled_gene Arg1:E10 Arg2:T38	
R30	Risk_Factor Arg1:E10 Arg2:T47	
R31	Risk_Factor Arg1:E10 Arg2:T48	
R32	Population_assignment Arg1:E10 Arg2:T46	
R33	Population_assignment Arg1:E7 Arg2:T46	
R34	Population_assignment Arg1:E10 Arg2:T19	
R35	Population_assignment Arg1:E7 Arg2:T19	
T52	Interaction 1481 1495	harboring both
E11	Interaction:T52 Entity:E12 Entity2:E13
T53	Interaction 1504 1518	haplotype GTAT
E12	Interaction:T53 
T54	Interaction 1542 1557	haplotype CATCG
E13	Interaction:T54 
T55	Entity 1561 1570	centrobin
T56	Entity 1522 1526	Nek2
R36	SNP_coupled_gene Arg1:E12 Arg2:T56	
R37	SNP_coupled_gene Arg1:E13 Arg2:T55	
T57	Entity 1475 1480	women
T58	Effect_Type 1588 1597	decreased
T59	Association 1612 1616	risk
E14	Association:T59 snp_int:E11 bc:T60
A8	Effect_Type E14 Decrease
R38	Effect_type_marker Arg1:E14 Arg2:T58	
R39	Population_assignment Arg1:E11 Arg2:T57	
R40	Population_assignment Arg1:E11 Arg2:T19	
T60	Cancer 1598 1611	breast cancer
T62	SNP 1658 1674	genetic variants
T63	Entity 1678 1682	Nek2
R41	SNP_coupled_gene Arg1:T62 Arg2:T63	
T64	Effect_Type 1687 1696	increased
T65	Cancer 1697 1710	breast cancer
T66	Association 1711 1715	risk
E15	Association:T66 bc:T65 snp_int:T62
A9	Effect_Type E15 Increase
R42	Effect_type_marker Arg1:E15 Arg2:T64	
T67	SNP 1732 1748	genetic variants
T68	Entity 1752 1761	centrobin
R43	SNP_coupled_gene Arg1:T67 Arg2:T68	
T69	Association 1531 1541	protective
E16	Association:T69 snp_int:E13 bc:T65
T61	Interaction 1638 1649;1720 1728	association modified
E17	Interaction:T61 Entity:T67 Entity2:T62
T70	Spec 1618 1628	suggesting
R44	Speculation_marker Arg1:E17 Arg2:T70	
E18	Association:T66 snp_int:E17 bc:T65
T71	SNP 1789 1810	genetic polymorphisms
T72	Entity 1814 1823	centrobin
T73	Entity 1828 1832	Nek2
R45	SNP_coupled_gene Arg1:T71 Arg2:T72	
T74	SNP 1789 1810	genetic polymorphisms
R46	SNP_coupled_gene Arg1:T74 Arg2:T73	
T75	Association 1837 1847	related to
E19	Association:T75 bc:T76 snp_int:E20
T76	Cancer 1848 1861	breast cancer
T77	Interaction 1824 1827	and
E20	Interaction:T77 Entity:T71 Entity2:T74
T78	Entity 1880 1897	Chinese Han women
R47	Population_assignment Arg1:E20 Arg2:T78	
R48	Population_assignment Arg1:T62 Arg2:T78	
R49	Population_assignment Arg1:T67 Arg2:T78	
R50	Equiv Arg1:E20 Arg2:E17	
